Lobbying Activity Report

6474-49960

Designated Filer name: Steve Vander Wal
Client: The Canadian Forum for Rare Disease Innovators (RAREi)
Would you like to identify any other entity with a direct interest in the outcome of this lobbying activity that worked together for the purpose of lobbying on any or all of the listed lobbying topics? No
Associated registration: 2215-6474-1
Lobbying Activity date: 2026-03-06
Arranged a meeting: Yes
Posted date: 2026-03-16

Senior Public Office Holders who were lobbied in this activity: Ian Rongve, ADM
Health System Policy & Oversight, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Provincial expensive drugs for rare disease program review and other rare disease-related policy issues
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Economic Development and Trade, Emergency Preparedness, Finances and Budgets, Health, Hospitals, Industry, Intellectual Property, International Trade, Mental Health and Addictions, Science and Technology
Return to Registration for Evonik Corporation
Date Modified: